These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 25380092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fractional CO2 laser versus trichloroacetic acid 50% for xanthelasma palpebrarum therapy.
    Al-Kady NA, Hamdino M, Abdel Kawy FAW.
    J Cosmet Dermatol; 2021 Mar; 20(3):763-768. PubMed ID: 32892481
    [Abstract] [Full Text] [Related]

  • 3. A prospective study comparing ultrapulse CO2 laser and trichloroacetic acid in treatment of Xanthelasma palpebrarum.
    Goel K, Sardana K, Garg VK.
    J Cosmet Dermatol; 2015 Jun; 14(2):130-9. PubMed ID: 25817385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Application of laser CO2 for the treatment of xanthelasma palpebrarum].
    Delgado Navarro C, Lanuza García A, Llorca Cardeñosa A, Bañón-Navarro R, Corchero Martin G.
    Arch Soc Esp Oftalmol; 2013 Aug; 88(8):320-2. PubMed ID: 23886365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of xanthelasma palpebrarum using a pulsed dye laser: a prospective clinical trial in 38 cases.
    Karsai S, Czarnecka A, Raulin C.
    Dermatol Surg; 2010 May; 36(5):610-7. PubMed ID: 20384756
    [Abstract] [Full Text] [Related]

  • 8. Systematic review of laser therapy in xanthelasma palpebrarum.
    Nguyen AH, Vaudreuil AM, Huerter CJ.
    Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Xanthelasma palpebrarum: treatment with the ultrapulsed CO2 laser.
    Raulin C, Schoenermark MP, Werner S, Greve B.
    Lasers Surg Med; 1999 Mar; 24(2):122-7. PubMed ID: 10100649
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fractional laser for vitiligo treated by 10,600 nm ablative fractional carbon dioxide laser followed by sun exposure.
    Hélou J, Maatouk I, Obeid G, Moutran R, Stéphan F, Tomb R.
    Lasers Surg Med; 2014 Aug; 46(6):443-8. PubMed ID: 24889492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Laser treatment of solar lentigines on dorsum of hands: QS Ruby laser versus ablative CO2 fractional laser - a randomized controlled trial.
    Schoenewolf NL, Hafner J, Dummer R, Bogdan Allemann I.
    Eur J Dermatol; 2015 Apr; 25(2):122-6. PubMed ID: 25788397
    [Abstract] [Full Text] [Related]

  • 18. About the treatment of xanthelasma palpebrarum using a 1,064 Q-switched neodymium-doped yttrium aluminum garnet laser.
    Fusade T.
    Dermatol Surg; 2011 Mar; 37(3):403-4. PubMed ID: 21410824
    [No Abstract] [Full Text] [Related]

  • 19. [KTP laser coagulation for xanthelasma palpebrarum].
    Berger C, Kopera D.
    J Dtsch Dermatol Ges; 2005 Oct; 3(10):775-9. PubMed ID: 16194155
    [Abstract] [Full Text] [Related]

  • 20. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
    Fusade T.
    Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.